Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robotic legs may help children with cerebral palsy walk better — a trial puts the technology to the test

NCT ID NCT07732205

Disease control Sponsor: Semmelweis University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 28, 2026 · Last updated Sep 01, 2026 · Updated 5 times

Summary

This trial investigates whether a robotic gait training system called Lokomat can improve standing, walking, and quality of life in children and young adults with cerebral palsy. Participants will receive 20 sessions of robot-assisted training over eight weeks, in addition to their usual rehabilitation. The study compares their progress to a control group that continues standard care alone. The goal is to see if this technology can help the brain learn new movement patterns and strengthen leg muscles.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lokomat robot-assisted gait training system
What this could lead to
If effective, this could provide a standardized, intensive therapy option to improve mobility and daily function in people with cerebral palsy.
What could go wrong
This is a small, single-center study with a quasi-experimental design, so results may not generalize widely. The optimal training protocol is still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 96 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 to 23 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children and young adult with cerebral palsy (GMFCS II-IV) * Age between 3-23 years, of both genders * Minimum length of femur: 21 centimeters * Hip X-ray not older than 3 months * Orthopedic specialist opinion and recommendation for robotic therapy treatment not older than one month * Valid medical referral for robotic therapy treatment * Signed consent form from the parent/custodian Exclusion Criteria: * Gross motor function classification GMFCS I or GMFCS V * Participation in robotic therapy at another location during the control group * The safety regulations and contraindications specified by the manufacturer are fully taken into account when using the Lokomat® robotic-assisted gait training system used in the study * The main contraindications for the use of Lokomat® include: * significant bone mineral density loss (osteopenia, osteoporosis) and increased fracture risk; * unhealed or unstable bone fractures; fixed joint contractures that significantly limit the range of motion; * medical conditions that prevent active rehabilitation participation (e.g. acute infection, severe respiratory or cardiovascular condition, significant cognitive or neuropsychological impairment); * anatomical or body size differences that prevent safe use of the device; * skin or soft tissue lesions that pose a risk of injury during use of the orthosis or suspension system.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cerebral palsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebral palsy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Semmelweis University, András Pető Rehabilitation and Health Care Department, Institutions of Conductive Pedagogical Center

    Budapest, Pest County, 1125, Hungary

More trials for these conditions

Other studies related to the condition(s) this trial covers.